Diabetes does not influence activation of coagulation, fibrinolysis or anticoagulant pathways in Gram-negative sepsis (melioidosis).

Koh, G; Meijers, J; Maude, R; Limmathurotsakul, D; Day, N; Peacock, S; van der Poll, T; Wiersinga, W

Journal article

Diabetes does not influence activation of coagulation, fibrinolysis or anticoagulant pathways in Gram-negative sepsis (melioidosis).

Abstract:: Diabetes is associated with a disturbance of the haemostatic balance and is an important risk factor for sepsis, but the influence of diabetes on the pathogenesis of sepsis remains unclear. Melioidosis ( Burkholderia pseudomallei infection) is a common cause of community-acquired sepsis in Southeast Asia and northern Australia. We sought to investigate the impact of pre-existing diabetes on the coagulation and fibrinolytic systems during sepsis caused by B.pseudomallei . We recruited a cohort of 44 patients (34 with diabetes and 10 without diabetes) with culture-proven melioidosis. Diabetes was defined as a pre-admission diagnosis of diabetes or an HbA₁c>7.8% at enrolment. Thirty healthy blood donors and 52 otherwise healthy diabetes patients served as controls. Citrated plasma was collected from all subjects; additionally in melioidosis patients follow-up specimens were collected seven and ≥ 28 days after enrolment where possible. Relative to uninfected healthy controls, diabetes per se (i.e. in the absence of infection) was characterised by a procoagulant effect. Melioidosis was associated with activation of coagulation (thrombin-antithrombin complexes (TAT), prothrombin fragment F₁+₂ and fibrinogen concentrations were elevated; PT and PTT prolonged), suppression of anti-coagulation (antithrombin, protein C, total and free protein S levels were depressed) and abnormalities of fibrinolysis (D-dimer and plasmin-antiplasmin complex [PAP] were elevated). Remarkably, none of these haemostatic alterations were influenced by pre-existing diabetes. In conclusion, although diabetes is associated with multiple abnormalities of coagulation, anticoagulation and fibrinolysis, these changes are not detectable when superimposed on the background of larger abnormalities attributable to B. pseudomallei sepsis.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Koh, G., Meijers, J., Maude, R., Limmathurotsakul, D., Day, N., Peacock, S., van der Poll, T., & Wiersinga, W. (2011). Diabetes does not influence activation of coagulation, fibrinolysis or anticoagulant pathways in Gram-negative sepsis (melioidosis). Thrombosis and Haemostasis, 106(6), 1139–1148.

MLA Style

Koh, G., et al. “Diabetes Does Not Influence Activation of Coagulation, Fibrinolysis or Anticoagulant Pathways in Gram-Negative Sepsis (Melioidosis).” Thrombosis and Haemostasis, vol. 106, no. 6, 2011, pp. 1139–48.

Chicago Style

Koh, G, J Meijers, R Maude, D Limmathurotsakul, N Day, S Peacock, T van der Poll, and W Wiersinga. 2011. “Diabetes Does Not Influence Activation of Coagulation, Fibrinolysis or Anticoagulant Pathways in Gram-Negative Sepsis (Melioidosis).” Thrombosis and Haemostasis 106 (6): 1139–48.
Share
Print